35,490 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Point72 Europe London LLP
Point72 Europe London LLP acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 35,490 shares of the biopharmaceutical company’s stock, valued at approximately $2,875,000. Several other […]
More Stories
S&T Bancorp, Inc. (NASDAQ:STBA) Director Sells $215,272.22 in Stock
S&T Bancorp, Inc. (NASDAQ:STBA – Get Free Report) Director Frank J. Palermo, Jr. sold 4,982 shares of the firm’s stock...
Stacy Hock Sells 8,571 Shares of Atlas Energy Solutions Inc. (NYSE:AESI) Stock
Atlas Energy Solutions Inc. (NYSE:AESI – Get Free Report) major shareholder Stacy Hock sold 8,571 shares of the company’s stock...
Short Interest in Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) Drops By 13.8%
Altisource Portfolio Solutions S.A. (NASDAQ:ASPS – Get Free Report) was the target of a large decrease in short interest during...
AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Down 14.0% in October
AquaBounty Technologies, Inc. (NASDAQ:AQB – Get Free Report) was the target of a large decline in short interest in October....
Schneider Downs Wealth Management Advisors LP Raises Stock Holdings in SPDR Portfolio Developed World ex-US ETF (NYSEARCA:SPDW)
Schneider Downs Wealth Management Advisors LP boosted its position in SPDR Portfolio Developed World ex-US ETF (NYSEARCA:SPDW – Free Report)...
ImmunoPrecise Antibodies (CVE:IPA) Trading Up 0.8% – Should You Buy?
ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s share price rose 0.8% on Friday . The stock traded as high...